180 related articles for article (PubMed ID: 7621575)
1. Mammosomatotroph adenoma causing gigantism in an 8-year old boy: a possible pathogenetic mechanism.
Dubuis JM; Deal CL; Drews RT; Goodyer CG; Lagacé G; Asa SL; Van Vliet G; Collu R
Clin Endocrinol (Oxf); 1995 May; 42(5):539-49. PubMed ID: 7621575
[TBL] [Abstract][Full Text] [Related]
2. Glycoprotein hormone alpha-subunit and prolactin release by cultured pituitary adenoma cells from acromegalic patients: correlation with GH release.
Hofland LJ; van Koetsveld PM; Verleun TM; Lamberts SW
Clin Endocrinol (Oxf); 1989 Jun; 30(6):601-11. PubMed ID: 2512040
[TBL] [Abstract][Full Text] [Related]
3. Hormone secretion in vitro by plurihormonal pituitary adenomas of the acidophil cell line.
Asa SL; Kovacs K; Horvath E; Singer W; Smyth HS
J Clin Endocrinol Metab; 1992 Jul; 75(1):68-75. PubMed ID: 1352308
[TBL] [Abstract][Full Text] [Related]
4. Distinct guanine nucleotide binding protein alpha-subunit receptor coupling in GH cell lines: effects of bromocriptine and hormones on effector enzyme modulation.
Johansen PW; Paulssen RH; Bjøro T; Gautvik KM; Gordeladze JO
Cell Physiol Biochem; 2001; 11(6):339-52. PubMed ID: 11832659
[TBL] [Abstract][Full Text] [Related]
5. Direct effects of catecholamines, thyrotropin-releasing hormone, and somatostatin on growth hormone and prolactin secretion from adenomatous and nonadenomatous human pituitary cells in culture.
Ishibashi M; Yamaji T
J Clin Invest; 1984 Jan; 73(1):66-78. PubMed ID: 6140273
[TBL] [Abstract][Full Text] [Related]
6. Effects of insulin-like growth factor-I on growth hormone and prolactin secretion and cell proliferation of human somatotrophinomas and prolactinomas in vitro.
Atkin SL; Landolt AM; Foy P; Jeffreys RV; Hipkin L; White MC
Clin Endocrinol (Oxf); 1994 Oct; 41(4):503-9. PubMed ID: 7525124
[TBL] [Abstract][Full Text] [Related]
7. Expression of functional growth hormone secretagogue receptors in human pituitary adenomas: polymerase chain reaction, triple in-situ hybridization and cell culture studies.
Barlier A; Zamora AJ; Grino M; Gunz G; Pellegrini-Bouiller I; Morange-Ramos I; Figarella-Branger D; Dufour H; Jaquet P; Enjalbert A
J Neuroendocrinol; 1999 Jul; 11(7):491-502. PubMed ID: 10444306
[TBL] [Abstract][Full Text] [Related]
8. Secretion of glycoprotein hormone alpha-subunit by pituitary tumors.
Ishibashi M; Yamaji T; Takaku F; Teramoto A; Fukushima T
J Clin Endocrinol Metab; 1987 Jun; 64(6):1187-93. PubMed ID: 2437140
[TBL] [Abstract][Full Text] [Related]
9. Congenital gigantism due to growth hormone-releasing hormone excess and pituitary hyperplasia with adenomatous transformation.
Zimmerman D; Young WF; Ebersold MJ; Scheithauer BW; Kovacs K; Horvath E; Whitaker MD; Eberhardt NL; Downs TR; Frohman LA
J Clin Endocrinol Metab; 1993 Jan; 76(1):216-22. PubMed ID: 8421089
[TBL] [Abstract][Full Text] [Related]
10. Characteristics of acromegalic patients with a good response to octreotide, a somatostatin analogue.
Yang IM; Woo JT; Kim SW; Kim JW; Kim YS; Choi YK
Clin Endocrinol (Oxf); 1995 Mar; 42(3):295-301. PubMed ID: 7758235
[TBL] [Abstract][Full Text] [Related]
11. [The relationship between TSH response to TRH and GH response to dopaminergic agents in patients with acromegaly].
Tokuyama T; Yoshinari M; Okamura K; Ikenoue H; Sato K; Kuroda T; Fujishima M
Nihon Naibunpi Gakkai Zasshi; 1991 Feb; 67(2):65-74. PubMed ID: 1674920
[TBL] [Abstract][Full Text] [Related]
12. Different responses of growth hormone secretion to guanfacine, bromocriptine, and thyrotropin-releasing hormone in acromegalic patients with pure growth hormone (GH)-containing and mixed GH/prolactin-containing pituitary adenomas.
Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ
J Clin Endocrinol Metab; 1985 Jun; 60(6):1148-53. PubMed ID: 3923021
[TBL] [Abstract][Full Text] [Related]
13. Prolactin-secreting pituitary adenoma in a man with gigantism: a case report.
Peillon F; Philippon J; Brandi AM; Fohanno D; Laplane D; Dubois MP; Decourt J
Acta Endocrinol (Copenh); 1979 Dec; 92(4):627-39. PubMed ID: 394552
[TBL] [Abstract][Full Text] [Related]
14. The role of prolactin in the inhibitory action of bromocriptine on growth hormone secretion in acromegaly.
Lamberts SW; Klijn JG; van Vroonhoven CC; Stefanko SZ; Liuzzi A
Acta Endocrinol (Copenh); 1983 Aug; 103(4):446-50. PubMed ID: 6310918
[TBL] [Abstract][Full Text] [Related]
15. Pit-1 gene expression in human pituitary adenomas using the reverse transcription polymerase chain reaction method.
Yamada S; Takahashi M; Hara M; Hattori A; Sano T; Ozawa Y; Shishiba Y; Hirata K; Usui M
Clin Endocrinol (Oxf); 1996 Sep; 45(3):263-72. PubMed ID: 8949563
[TBL] [Abstract][Full Text] [Related]
16. Hormone secretion by cell culture of human GH-PRL secreting pituitary adenomas: effects of bromocriptine.
Lei T; Bai X; Liu K; Hu W; Xue D; Jiang X
J Tongji Med Univ; 1998; 18(3):161-3. PubMed ID: 10806816
[TBL] [Abstract][Full Text] [Related]
17. Pathological and experimental investigations in a case of gigantism.
Fazekas I; Pásztor E; Slowik F; Bálint K; Dobronyi I; Bácsy E; Gyévai A; Péter F; Blatniczky L; Varga I
Acta Neuropathol; 1993; 85(2):167-74. PubMed ID: 8382895
[TBL] [Abstract][Full Text] [Related]
18. Long-term in-vitro treatment of human growth hormone (GH)-secreting pituitary adenoma cells with octreotide causes accumulation of intracellular GH and GH mRNA levels.
Hofland LJ; Velkeniers B; vd Lely AJ; van Koetsveld PM; Kazemzadeh M; Waaijers M; Hooghe-Peters EL; Lamberts SW
Clin Endocrinol (Oxf); 1992 Sep; 37(3):240-8. PubMed ID: 1424206
[TBL] [Abstract][Full Text] [Related]
19. Five-year follow-up of a 13-year-old boy with a pituitary adenoma causing gigantism--effect of octreotide therapy.
Schoof E; Dörr HG; Kiess W; Lüdecke DK; Freitag E; Zindel V; Rascher W; Dötsch J
Horm Res; 2004; 61(4):184-9. PubMed ID: 14739526
[TBL] [Abstract][Full Text] [Related]
20. A comparison between the effects of SMS 201-995, bromocriptine and a combination of both drugs on hormone release by the cultured pituitary tumour cells of acromegalic patients.
Lamberts SW; Verleun T; Hofland L; Del Pozo E
Clin Endocrinol (Oxf); 1987 Jul; 27(1):11-23. PubMed ID: 2888550
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
